Emmanuelle Boishardy – General Manager, GSK Czech Republic
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
Egis Pharmaceuticals PLC is one of the leading generic pharmaceutical companies in Central Eastern Europe with activities extending to every field of pharmaceutical production from research and development, through active ingredient and finished production to sales and marketing.
In the past one hundred years that have passed since the foundation of Egis in 1913, Egis has grown into an internationally renowned company with about 4000 employees worldwide.
Egis products are sold to 60 countries and 75 percent of its turnover derives from exports. Egis drugs acting on the cardiovascular, central nervous and respiratory systems account for almost three-quarters of our turnover and we are continuously open towards new areas. In 2013, Egis launched Europe’s first biosimilar monoclonal antibody and it is our strategic goal to become a key player in the biosimilar therapies’ segment.
Contact
Address: Ovocný trh 1096/8, Praha, Czech Republic
Phone number: +420 227 129 111
Homepage: http://www.egispraha.cz/
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the company’s success in the Central Eastern European region. Corina…
Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in the challenging Czech generics market and shares his…
Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which relies on the indispensable cooperation between specialists…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market in the Czech Republic, gives an overview of the current…
Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the Institute of Health Economics and Technology Assessment (iHETA), gives an overview…
Sandoz’s Jiří Hanzlík, country head for the Czech Republic, evaluates the Czech affiliate’s role in contributing to the success of Sandoz globally as well as its position in the country.…
Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement scheme the association has worked on alongside other key stakeholders in…
Bioinova’s CEO and managing director MUDr Peter Bauer PhD introduces the biotech company’s shift from a university spin-off to a privately held entity. Whilst describing the powerful properties of stem…
Štěpán Svačina, Chairman of the Czech Medical Association (CzMA), gives insights into the challenges that the Czech Republic faces in bringing change to the life sciences infrastructure. Whilst pointing out…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
See our Cookie Privacy Policy Here
